Company Filing History:
Years Active: 1999-2002
Title: The Innovative Contributions of Dieter Kuhn
Introduction
Dieter Kuhn, a prominent inventor based in Marburg, Germany, has made significant strides in the pharmaceutical field. With a total of two patents to his name, Kuhn's innovative techniques and formulations have the potential to enhance the effectiveness of drug delivery systems.
Latest Patents
Kuhn's latest patents focus on the development of multiple unit oral pharmaceutical dosage forms, specifically related to Tramadol formulations. His first patent describes a multiple unit oral pharmaceutical dosage form that comprises a plurality of pellets contained within a water-soluble capsule or tablet. Each pellet features a substantially inert core, coated with an active ingredient layer that includes a pharmacologically active particulate ingredient and a binding agent. This innovative design aims to retard the release of the active ingredient into an aqueous body fluid, ensuring controlled and effective release.
The second patent also centers on multiple unit oral pharmaceutical formulations, reiterating the same foundational design but illustrating variations in the composition and proportions of the binder and the inert materials used in the process. By optimizing the ratios of ethylcellulose and shellac, along with incorporating water-insoluble particulate materials like talcum, Kuhn's patents offer a method to improve the pharmacokinetics of the drug while ensuring patient safety.
Career Highlights
Throughout his career, Dieter Kuhn has contributed to major advancements in pharmaceutical formulations. He has held significant roles at leading companies in the industry, including Asta Medica and Asto-Medica AG. His expertise in drug delivery systems has allowed him to pioneer formulations that enhance the therapeutic benefits of various medications.
Collaborations
Kuhn has worked alongside notable industry coworkers such as Helmut Momberger and Marc Raber. Their collaborative efforts in research and development have contributed to advancing the fields of pharmaceutical sciences and innovation.
Conclusion
Dieter Kuhn's dedication to improving pharmaceutical formulations through innovative patents demonstrates his valuable contributions to the field. His work not only reflects the intricate nature of drug delivery systems but also underscores the importance of scientific collaboration among industry professionals. As the pharmaceutical industry continues evolving, inventors like Kuhn remain at the forefront, developing solutions that can significantly impact healthcare.